A study evaluating distribution and extent of tau pathology in Alzheimer's disease and progressive supranuclear palsy.
Phase of Trial: Phase II
Latest Information Update: 15 Jun 2017
At a glance
- Drugs Flortaucipir F 18 (Primary)
- Indications Alzheimer's disease; Mild cognitive impairment; Progressive supranuclear palsy
- Focus Diagnostic use
- 15 Jun 2017 New trial record